Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,484 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retraction Note: Microbiome analyses of blood and tissues suggest cancer diagnostic approach.
Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf J, Song SJ, Kanbar J, Miller-Montgomery S, Heaton R, Mckay R, Patel SP, Swafford AD, Knight R. Poore GD, et al. Among authors: mckay r. Nature. 2024 Jul;631(8021):694. doi: 10.1038/s41586-024-07656-x. Nature. 2024. PMID: 38926587 No abstract available.
Robustness of cancer microbiome signals over a broad range of methodological variation.
Sepich-Poore GD, McDonald D, Kopylova E, Guccione C, Zhu Q, Austin G, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf JL, Song SJ, Kanbar J, Miller-Montgomery S, Heaton R, Mckay R, Patel SP, Swafford AD, Korem T, Knight R. Sepich-Poore GD, et al. Among authors: mckay r. Oncogene. 2024 Apr;43(15):1127-1148. doi: 10.1038/s41388-024-02974-w. Epub 2024 Feb 23. Oncogene. 2024. PMID: 38396294 Free PMC article.
Correction: Robustness of cancer microbiome signals over a broad range of methodological variation.
Sepich-Poore GD, McDonald D, Kopylova E, Guccione C, Zhu Q, Austin G, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf JL, Song SJ, Kanbar J, Miller-Montgomery S, Heaton R, Mckay R, Patel SP, Swafford AD, Korem T, Knight R. Sepich-Poore GD, et al. Among authors: mckay r. Oncogene. 2024 May;43(20):1579. doi: 10.1038/s41388-024-03018-z. Oncogene. 2024. PMID: 38580705 Free PMC article. No abstract available.
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers.
Muquith M, Espinoza M, Elliott A, Xiu J, Seeber A, El-Deiry W, Antonarakis ES, Graff SL, Hall MJ, Borghaei H, Hoon DSB, Liu SV, Ma PC, McKay RR, Wise-Draper T, Marshall J, Sledge GW, Spetzler D, Zhu H, Hsiehchen D. Muquith M, et al. Among authors: mckay rr. Nat Cancer. 2024 Jul;5(7):1121-1129. doi: 10.1038/s43018-024-00752-x. Epub 2024 Mar 25. Nat Cancer. 2024. PMID: 38528112
Accelerating precision medicine in metastatic prostate cancer.
Mateo J, McKay R, Abida W, Aggarwal R, Alumkal J, Alva A, Feng F, Gao X, Graff J, Hussain M, Karzai F, Montgomery B, Oh W, Patel V, Rathkopf D, Rettig M, Schultz N, Smith M, Solit D, Sternberg C, Van Allen E, VanderWeele D, Vinson J, Soule HR, Chinnaiyan A, Small E, Simons JW, Dahut W, Miyahira AK, Beltran H. Mateo J, et al. Among authors: mckay r. Nat Cancer. 2020 Nov;1(11):1041-1053. doi: 10.1038/s43018-020-00141-0. Epub 2020 Nov 17. Nat Cancer. 2020. PMID: 34258585 Free PMC article.
HSD3B1, prostate cancer mortality and modifiable outcomes.
Freitas PFS, Abdshah A, McKay RR, Sharifi N. Freitas PFS, et al. Among authors: mckay rr. Nat Rev Urol. 2024 Nov 14. doi: 10.1038/s41585-024-00953-0. Online ahead of print. Nat Rev Urol. 2024. PMID: 39543357 Review.
Cancer, more than a "COVID-19 co-morbidity".
Jani CT, Schooley RT, Mckay RR, Lippman SM. Jani CT, et al. Among authors: mckay rr. Front Oncol. 2023 Mar 13;13:1107384. doi: 10.3389/fonc.2023.1107384. eCollection 2023. Front Oncol. 2023. PMID: 36994197 Free PMC article. Review.
1,484 results